| ID | Type | Location (GRCh37) | Location (GRCh38) | Length | GC content |
|---|---|---|---|---|---|
| hsa_chr9_0073500 | Intergenic-Intergenic | chr9:113703564-113703895 | chr9:110941284-110941615 | 332 nt | 0.4337 |
| hsa_LPAR1_0003100 | Intron-Exon-Intron | chr9:113703701-113741039 | chr9:110941421-110978759 | 148 nt | 0.4257 |
| hsa_LPAR1_0003200 | Intron-Exon-Intron | chr9:113703701-113771455 | chr9:110941421-111009175 | 28 nt | 0.3214 |
| hsa_LPAR1_0003300 | Intron-Exon-Intron | chr9:113703701-113773990 | chr9:110941421-111011710 | 163 nt | 0.3681 |
| hsa_LPAR1_0002900 | Intron-Exon-Intron | chr9:113703701-113779408 | chr9:110941421-111017128 | 250 nt | 0.4080 |
| hsa_LPAR1_0003000 | Intron-Exon-Intron | chr9:113703701-113783270 | chr9:110941421-111020990 | 250 nt | 0.3560 |
| hsa_chr9_0073600 | Intergenic-Intergenic | chr9:113704293-113734416 | chr9:110942013-110972136 | 248 nt | 0.4718 |
| hsa_chr9_0073700 | Intergenic-Intergenic | chr9:113704293-113735805 | chr9:110942013-110973525 | 377 nt | 0.4748 |
| hsa_LPAR1_0003400 | Exon-Intron | chr9:113704316-113798481 | chr9:110942036-111036201 | 467 nt | 0.4904 |
| hsa_LPAR1_0003500 | Exon-Intron | chr9:113704316-113798532 | chr9:110942036-111036252 | 131 nt | 0.4885 |
A study in humans demonstrated that the circLPAR1 is expressed at low levels in muscle-invasive bladder cancer (MIBC) tissues, where its low expression predicts worse disease-specific survival and is associated with invasion and metastasis [Di Agostino et al. DOI:10.3389/fcell.2020.00389].